Angiomyolipoma risk factors

Angiomyolipoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Angiomyolipoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Angiomyolipoma risk factors On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Angiomyolipoma risk factors All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Angiomyolipoma risk factors
CDC on Angiomyolipoma risk factors
Angiomyolipoma risk factors in the news
Blogs on Angiomyolipoma risk factors
Directions to Hospitals Treating Angiomyolipoma
Risk calculators and risk factors for Angiomyolipoma risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]

Overview

20% cases of angiomyolipoma are seen in association with phakomatoses, the vast majority in the setting of tuberous sclerosis, although they have also been described in setting of Von Hippel-Lindau syndrome (VHL) and neurofibromatosis type 1 (NF1)